Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial

Journal of Clinical Psychiatry

Volumn 75, Issue 3, 2014, Pages

  Fleischhacker, W Wolfgang ^a   Kane, John M ^a   Geier, Jamie ^a   Karayal, Onur ^a   Kolluri, Sheela ^a   Eng, Sybil M ^a   Reynolds, Robert F ^a   Strom, Brian L ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; OLANZAPINE; ZIPRASIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SUICIDE; SUICIDE ATTEMPT; DRUG EFFICACY; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; ANTIPSYCHOTIC AGENTS; ASIA; BENZODIAZEPINES; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; PIPERAZINES; RISK FACTORS; SCHIZOPHRENIA; SUICIDE; SUICIDE, ATTEMPTED; THIAZOLES; TIME FACTORS; UNITED STATES;

EID: 84898744645     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.13m08563     Document Type: Article

References (45)

1. Carlborg A, Winnerback K, Jdnsson EG, et al. Suicide in schizophrenia. Expert Rev Neurother. 2010;10(7):1153-1164.
2. Baxter D, Appleby L. Case register study of suicide risk in mental disorders. Br J Psychiatry. 1999;175(10):322-326.
3. Osby U, Correia N, Brandt L, et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 2000;45(1-2):21-28.
4. Barak Y, Baruch Y, Achiron A, et al. Suicide attempts of schizophrenia patients: a case-controlled study in tertiary care. Psychiatr Res. 2008;42(10):822-826.
5. Heila H, Haukka J, Suvisaari J, et al. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med. 2005;35(5):725-732.
6. Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. JPsychopharmacol. 2010;24(supp1):81-90.
7. Gomez-Duran EL, Martin-Fumado C, Hurtado-Ruiz G. Clinical and epidemiological aspects of suicide in patients with schizophrenia. Adas Esp Psiquiatr. 2012;40(6):333-345.
8. Caldwell CB, Gottesman II. Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bu11. 1990;16(4):571-589.
9. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005;62(3):247-253.
10. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10): 1123-1131.
11. Planansky K, Johnston R. The occurrence and characteristics of suicidal preoccupation and acts in schizophrenia. Ada Psychiatr Scand. 1971;47(4): 473-483.
12. Landmark J, Cernovsky ZZ, Merskey H. Correlates of suicide attempts and ideation in schizophrenia. Br J Psychiatry. 1987;151:18-20.
13. Drake RE, Gates C, Cotton PG. Suicide among schizophrenics: a comparison of attempters and completed suicides. Br J Psychiatry. 1986;149:784-787.
14. Harris EC, Barradough B. Excess mortality of mental disorder. BrJ Psychiatry. 1998;173:11-53.
15. Carlborg A, Jokinen J, Nordstrom AL, et al. Attempted suicide predicts suicide risk in schizophrenia spectrum psychosis. Nord J Psychiatry. 2010; 64(1):68-72.
16. Harkavy-Friedman JM, Restifo K, Malaspina D, et al. Suicidal behavior in schizophrenia: characteristics of individuals who had and had not attempted suicide. Am J Psychiatry. 1999;156(8):1276-1278.
17. Strom BL, Faich GA, Reynolds RF, et al. The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics. Clin Psychiatry. 2008;69(1):114-121.
18. Strom BL, Eng SM, Faich G, et al. Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). Am J Psychiatry. 2011;168(2):193-201.
19. March JS, Silva SG, Compton S, et al. The case for practical clinical trials in psychiatry. Am J Psychiatry. 2005;162(5):836-846.
20. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.
21. CDC. National Death Index, http://www.cdc.gov/nchs/ndi.htm. Updated February 21,2013. Accessed December 23,2013.
22. Crocq MA, Naber D, Lader MH, et al. Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone. Eur Neuropsychopharmacol. 2010;20(12):829-838.
23. Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry. 1991;36(4):239-245.
24. Allgulander C, Allebeck P, Przybeck TR, et al. Risk of suicide by psychiatric diagnosis in Stockholm County: a longitudinal study of 80,970 psychiatric inpatients. Eur Arch Psychiatry Clin Neurosci. 1992;241(5):323-326.
25. Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry. 1993;163:183-189.
26. SernyakMJ, Desai R, Stolar M, et al. Impact of dozapine on completed suicide. Am J Psychiatry. 2001;158(6):931-937.
27. Besnier N, Gavaudan G, Navez A, et al. Clinical features of suicide occurring in schizophrenia, 1: risk-factors identification [in French]. Encephale. 2009; 35(2):176-181.
28. Dutta R, Murray RM, Hotopf M, et al. Reassessing the long-term risk of suicide after a first episode of psychosis. Arch Gen Psychiatry. 2010;67(12): 1230-1237.
29. Osborn D, Levy G, Nazareth I, et al. Suicide and severe mental illnesses: cohort study within the UK general practice research database. Schizophr Res. 2008;99(1-3):134-138.
30. Thong JY, Su AH, Chan YH, et al. Suicide in psychiatric patients: case-control study in Singapore. Aust NZJ Psychiatry. 2008;42(6):509-5l9.
31. Melle I, Johannessen JO, Friis S, et al. Course and predictors of suicidality over the first two years of treatment in first-episode schizophrenia spectrum psychosis. Arch SuicideRes. 2010;14(2):158-170.
32. Carlborg A, Jokinen J, Jonsson EG, et al. Long-term suicide risk in schizophrenia spectrum psychoses: survival analysis by gender. Arch Suicide Res. 2008;12(4):347-351.
33. Kasckow J, Liu N, Haas GL, et al. Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in China. Schizophr Res. 2010;122(1-3): 226-231.
34. Neuner T, Hiibner-Liebermann B, Haen E, et al; AGATE. Completed suicides in 47 psychiatric hospitals in Germany-results from the AGATE-study. Pharmacopsychiatry. 2011;44(7):324-330.
35. Pompili M, Lester D, Grispini A, et al. Completed suicide in schizophrenia: evidence from a case-control study. Psychiatry Res. 2009;167(3):251-257.
36. Reutfors J, Brandt L, Jonsson EG, et al. Risk factors for suicide in schizophrenia: findings from a Swedish population-based case-control study. Schizophr Res. 2009;108(1-3):231-237.
37. Montross LP, Kasckow J, Golshan S, et al. Suicidal ideation and suicide attempts among middle-aged and older patients with schizophrenia spectrum disorders and concurrent subsyndromal depression. J Nerv Ment Dis. 2008; 196(12):884-890.
38. Uzun O, Tamam L, Ozciiler T, et al. Specific characteristics of suicide attempts in patients with schizophrenia in Turkey, fer /Psychiatry Relat Sci. 2009;46(3):189-194.
39. Zhang XY, Al Jurdi RK, Zoghbi AW, et al. Prevalence, demographic and clinical correlates of suicide attempts in Chinese medicated chronic inpatients with schizophrenia. J Psychiatr Res. 2013;47(10):1370-1375.
40. Brecic P, Ostojic D, Vidovic D, et al. Characteristics of patients who committed suicide during hospitalization in Psychiatric Hospital "Vrapce" in the period 1996-2006. Co11 Antropol. 2009;33(1):233-236.
41. Chen YY, Lee MB, Chang CM, et al. Methods of suicide in different psychiatric diagnostic groups. J Affect Disord. 2009;118(1-3):196-200.
42. Perlis RH. Hard outcomes: clinical trials to reduce suicide. Am J Psychiatry. 2011;168(10):1009-1011.
43. Karayal ON, Anway SD, Batzar E, et al. Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone. Clin Psychiatry. 2011;72(3):367-375.
44. Harkavy-Friedman JM, Nelson EA, Venarde DF, et al. Suicidal behavior in schizophrenia and schizoaffective disorder: examining the role of depression. Suicide Life Threat Behav. 2004;34(1):66-76.
45. Hawton K, Sutton L, Haw C, et al. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry. 2005;187(7):9-20.